Skip to main content
. Author manuscript; available in PMC: 2020 Sep 29.
Published in final edited form as: Med Dosim. 2018 May 22;44(2):150–154. doi: 10.1016/j.meddos.2018.04.006

Table 1.

Institutional planning criteria for VMAT/IMRT Breast/Chestwall. Quantities in parentheses are the highest permitted without special physician consideration.

Target Criteria Note

PTV D95% 95%
D05% 115% Inside Implant D05<=120%
IMN PTV D95% 100% IMN D95%≥90% only if OK with MD and if it helps reduce Heart Mean Dose

Normal Tissue Criteria

Ideal (Acceptable)
Non DIBH DIBH
Ipsilateral Lung V20Gy 30% (33%) 27% (30%)
V10Gy 65% (68%) 60% (63%)
Mean Dose 18Gy 18Gy
Contralateral Lung V20Gy 5%
Heart V25Gy 3% If Left Sided
0.5% If Right Sided
Max. Point Dose 50Gy
Mean Dose 7Gy(8Gy) 6Gy(7Gy) If Left Sided and IMN D95%>=90%
4Gy If Right Sided and IMN D95%>=90%
10Gy If Left Sided and IMN D95%>=100%
5Gy If Right Sided and IMN D95%>=100%
Left Anterior descending Artery Max. Point Dose 25Gy(35Gy)
Thyroid Mean Dose 20 Gy
Esophagus Max Point Dose 35 Gy(40Gy)
Ipsilateral Brachial Plexus Max. Point Dose 55Gy
Contralateral Intact Breast Mean Dose 6Gy
Contralateral Implant Mean Dose 8Gy
Liver Mean Dose 8Gy (10Gy) For Right Sided
Stomach Mean Dose 5Gy 3Gy For Left Sided
Cord Max Point Dose 20Gy